Weekend-off ART is non-inferior to continuous ART in young people taking efavirenz-based regimens: results from BREATHER study
24 March 2015. Related: Conference reports, Treatment strategies, Paediatric care.
CROI 21 (Retrovirus) 2014
21st Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014, Boston
27 May 2014. Related: Conference reports.
Pharmacokinetics of antiretrovirals in pregnancy
27 May 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Better virologic outcomes with efavirenz vs lopinavir/ritonavir in pregnant women and no difference in risk of preterm birth
27 May 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
Once daily lopinavir/ritonavir not recommended for routine use in children and adolescents
27 May 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Early antiretroviral treatment in infants
27 May 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Hospitalisation among elite controllers
27 May 2014. Related: Conference reports, Treatment strategies.
Catching up with pathogenesis and cure research from CROI 2014
27 May 2014. Related: Conference reports, Paediatric care, Cure-related research.
21st Conference on Retroviruses and Opportunistic Infections (CROI), 3-6 March 2014, Boston
24 March 2014. Related: Conference reports.
No HIV transmissions with undetectable viral load: interim PARTNER study results show need for longer follow-up
24 March 2014. Related: Conference reports, HIV prevention and transmission.
PrEP injections every three months may protect against exposure from anal sex
24 March 2014. Related: Conference reports, HIV prevention and transmission.
ARV pipeline: doravirine, GSK-744 and BMS-068
24 March 2014. Related: Conference reports, Antiretrovirals.
Viral load rebound rate of 35% using ritonavir-boosted PI monotherapy: results of five-year PIVOT study
24 March 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
Dual therapy less effective at high viral load: NEAT 001 study with raltegravir/darunavir/r
24 March 2014. Related: Conference reports, Antiretrovirals, Treatment strategies.
Pharmacokinetic targets for efavirenz might be too high
24 March 2014. Related: Conference reports, Antiretrovirals, PK and drug interactions.
Abacavir link to cardiovascular events in high-risk patients maintained in D:A:D study
24 March 2014. Related: Conference reports, Side effects.
NNRTI resistance found in 12% of people stopping treatment with undetectable viral load: implications for stock-outs
24 March 2014. Related: Conference reports, Treatment strategies, Drug resistance.
HIV related infections remain the leading cause of maternal deaths in South Africa despite the availability of ART
24 March 2014. Related: Conference reports, Pregnancy.
Lower newborn bone mineral content with maternal tenofovir use
24 March 2014. Related: Conference reports, Pregnancy.
Paediatric pipeline: CROI 2014 update on new antiretrovirals for children
24 March 2014. Related: Conference reports, Paediatric care.
Efavirenz maintenance therapy effective in children exposed to nevirapine prophylaxis
24 March 2014. Related: Conference reports, Paediatric care.
Xpert TB test has important advantages but does not reduce morbidity
24 March 2014. Related: Conference reports, TB coinfection.
Reports of a second baby possibly cured of HIV: uncertainty remains
24 March 2014. Related: Conference reports, Cure-related research, Basic science and immunology.
Updates on SB728-T, a CCR5-targeting gene therapy
24 March 2014. Related: Conference reports, Cure-related research, Basic science and immunology.